Phio Pharmaceuticals Corp. (PHIO)
NASDAQ: PHIO · Real-Time Price · USD
2.470
-0.060 (-2.37%)
At close: Nov 22, 2024, 4:00 PM
2.460
-0.010 (-0.40%)
After-hours: Nov 22, 2024, 4:05 PM EST
Phio Pharmaceuticals Employees
As of December 31, 2023, Phio Pharmaceuticals had 9 total employees, including 8 full-time and 1 part-time employees. The number of employees decreased by 1 or -10.00% compared to the previous year.
Employees
9
Change (1Y)
-1
Growth (1Y)
-10.00%
Revenue / Employee
n/a
Profits / Employee
-$824,333
Market Cap
2.13M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Xylo Technologies | 84 |
Scorpius Holdings | 84 |
Molecular Templates | 62 |
Nuwellis | 59 |
Sonnet BioTherapeutics Holdings | 12 |
Dermata Therapeutics | 8 |
180 Life Sciences | 4 |
GRI Bio | 4 |
PHIO News
- 3 days ago - Phio Pharmaceuticals Announces Completion of Enrollment in Second Cohort in Phase 1b Dose-Escalating Clinical Study - Newsfile Corp
- 8 days ago - Phio Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business Update - Newsfile Corp
- 15 days ago - Phio Pharmaceuticals Announces Upcoming Presentation at the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC) - Newsfile Corp
- 21 days ago - Phio Pharmaceuticals to Participate in the Renmark Financial Communications Virtual Non-Deal Roadshow Series - Newsfile Corp
- 5 weeks ago - Correction to Registration Link to Access Phio Pharmaceuticals' Presentation in the Renmark Financial Communications Virtual Non-Deal Roadshow Series - Newsfile Corp
- 5 weeks ago - Phio Pharmaceuticals to Participate in the Renmark Financial Communications Virtual Non-deal Roadshow Series - Newsfile Corp
- 5 weeks ago - Phio Pharmaceuticals Presenting Data on Its INSTAYL Compound PH-894 at ASGCT's 2024 Advancing Gene and Cell Therapies for Cancer Conference - Newsfile Corp
- 6 weeks ago - Phio Announces Data Showcasing INTASYL's Role in Helping Immune Cells Target and Kill Cancer Cells - Newsfile Corp